Salomon Melgen’s conviction on Medicare fraud charges is unlikely to alter the landscape in the corruption case against U.S. Sen. Robert Menendez, according to legal observers.
Already facing an uphill battle due to a July 2016 U.S. Supreme Court ruling narrowing the scope of official conduct qualifying as an element of bribery, prosecutors in the Menendez case are unlikely to reap any benefit from Melgen’s Medicare fraud prosecution, according to lawyers familiar with the case.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
